Suchergebnisse - "Hess, Lisa M."

PubPharm (161)

1

Biomarker Testing, Targeted Therapy and Clinical Trial Participation by Race Among Patients With Lung Cancer : A Real-World Medicaid Database Study

enthalten in: JTO clinical and research reports | 2024

von Bruno, D. | Li, X. | Hess, L.

2

Mixed-methods research to support the use of new lymphoma-specific patient-reported symptom measures derived from the EORTC item library

enthalten in: Journal of patient-reported outcomes | 2024

von Markowitz, J. | Mazerolle, F. | Lovell, T. | +4

3

Mixed-methods research to support the use of new lymphoma-specific patient-reported symptom measures derived from the EORTC item library

enthalten in: Journal of patient-reported outcomes | 2024

von Markowitz, J. | Mazerolle, F. | Lovell, T. | +4

4

Pirtobrutinib versus venetoclax in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia : a matching-adjusted indirect comparison

enthalten in: Haematologica | 2023

von Al-Sawaf, O. | Jen, M. | Hess, L. | +6

5

Biomarker Testing, Treatment, and Outcomes in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Using a Real-World Database

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2023

von Bhandari, N. | Hess, L. | He, D. | +1

6

Real-World Biomarker Testing Patterns in Patients With Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in a US Community-Based Oncology Practice Setting

enthalten in: Clinical lung cancer | 2023

von Sireci, A. | Krein, P. | Hess, L. | +7

7

Clinical outcomes among patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who received treatment with a covalent BTK and BCL2 inhibitor in the United States : a real-world database study

enthalten in: Leukemia & lymphoma | 2023

von Eyre, T. | Hess, L. | Sugihara, T. | +8

8

Correction : Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States

enthalten in: BMC cancer | 2023

von Hess, L. | Han, Y. | Zhu, Y. | +2

ErratumFor: BMC Cancer. 2021 Jan 5;21(1):28. - PMID 33402119

9

Correction: Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States

enthalten in: BMC cancer | 2023

von Hess, L. | Han, Y. | Zhu, Y. | +2

10

Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the USA

enthalten in: Personalized medicine | 2023

von Bhandari, N. | Hess, L. | Parikh, R. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]